Christopher Codeanne, MBA, CPA

Chief Financial Officer at FIGUR8, Inc.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Boston, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Certified Public Accountant
    -

Experience

    • United States
    • Hospitals and Health Care
    • 1 - 100 Employee
    • Chief Financial Officer
      • Jan 2023 - Present

    • United States
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Advisory Board Member
      • Feb 2018 - Present

      Clinical Maestro is a revolutionary platform of modular and integrated business applications. It enables all participants in clinical trials, Sponsor Companies and Service Providers, to plan studies, model and manage clinical contracts in an entirely novel way. Faster. More accurately. With less effort. Clinical Maestro is a revolutionary platform of modular and integrated business applications. It enables all participants in clinical trials, Sponsor Companies and Service Providers, to plan studies, model and manage clinical contracts in an entirely novel way. Faster. More accurately. With less effort.

    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Chief Financial Officer
      • Jul 2018 - Dec 2022

      ConcertAI’s mission is to drive better patient outcomes with leading RWD and AI SaaS solutions ConcertAI’s mission is to drive better patient outcomes with leading RWD and AI SaaS solutions

    • United States
    • Venture Capital and Private Equity Principals
    • 1 - 100 Employee
    • Executive In Residence
      • 2018 - 2020

    • United States
    • Plastics Manufacturing
    • 1 - 100 Employee
    • Chief Financial Officer
      • Jul 2014 - Feb 2018

      A recognized leader in advanced materials science, Oxford Performance Materials Inc. (OPM) was founded in 2000 to exploit and commercialize the world’s highest performing thermoplastics, with a focus on poly-ether-ketone-ketone (PEKK). OPM develops proprietary material, process and application technologies and applies high performance additive manufacturing (HPAM™) to produce fully functional end-use structural parts. The Company has three strategic business units: OPM Materials develops… Show more A recognized leader in advanced materials science, Oxford Performance Materials Inc. (OPM) was founded in 2000 to exploit and commercialize the world’s highest performing thermoplastics, with a focus on poly-ether-ketone-ketone (PEKK). OPM develops proprietary material, process and application technologies and applies high performance additive manufacturing (HPAM™) to produce fully functional end-use structural parts. The Company has three strategic business units: OPM Materials develops proprietary OXPEKK® thermoplastic products and other materials for biomedical, aerospace and industrial applications. OPM Aerospace & Industrial produces 3D printed OXFAB® production parts for highly demanding aerospace, satellite and defense applications. OXFAB® structures offer significant weight, cost and time-to-market reductions that are defined in a set of specified performance attributes in the exhaustive OPM B-Basis database, developed in conjunction with NASA. OPM Biomedical is a pioneer in personalized medicine, 3D printing OsteoFab® cranial and facial implants as an OEM, and its SpineFab® line on a contract manufacturing basis. OPM Biomedical is the first and only company to receive FDA 510(k) clearance to manufacture 3D printed patient-specific polymeric implants, and has a total of four 510(k) clearances in its portfolio. For more information, please visit: Show less A recognized leader in advanced materials science, Oxford Performance Materials Inc. (OPM) was founded in 2000 to exploit and commercialize the world’s highest performing thermoplastics, with a focus on poly-ether-ketone-ketone (PEKK). OPM develops proprietary material, process and application technologies and applies high performance additive manufacturing (HPAM™) to produce fully functional end-use structural parts. The Company has three strategic business units: OPM Materials develops… Show more A recognized leader in advanced materials science, Oxford Performance Materials Inc. (OPM) was founded in 2000 to exploit and commercialize the world’s highest performing thermoplastics, with a focus on poly-ether-ketone-ketone (PEKK). OPM develops proprietary material, process and application technologies and applies high performance additive manufacturing (HPAM™) to produce fully functional end-use structural parts. The Company has three strategic business units: OPM Materials develops proprietary OXPEKK® thermoplastic products and other materials for biomedical, aerospace and industrial applications. OPM Aerospace & Industrial produces 3D printed OXFAB® production parts for highly demanding aerospace, satellite and defense applications. OXFAB® structures offer significant weight, cost and time-to-market reductions that are defined in a set of specified performance attributes in the exhaustive OPM B-Basis database, developed in conjunction with NASA. OPM Biomedical is a pioneer in personalized medicine, 3D printing OsteoFab® cranial and facial implants as an OEM, and its SpineFab® line on a contract manufacturing basis. OPM Biomedical is the first and only company to receive FDA 510(k) clearance to manufacture 3D printed patient-specific polymeric implants, and has a total of four 510(k) clearances in its portfolio. For more information, please visit: Show less

    • United States
    • Biotechnology Research
    • 700 & Above Employee
    • Chief Operating Officer and Chief Financial Officer
      • Dec 2010 - Jul 2014

      Board of Directors | December 2010 - July 2014 Chief Operating and Chief Financial Officer | January 2014 - July 2014 EVP, Chief Financial Officer | December 2010 - December 2013 Board of Directors | December 2010 - July 2014 Chief Operating and Chief Financial Officer | January 2014 - July 2014 EVP, Chief Financial Officer | December 2010 - December 2013

    • United States
    • Pharmaceutical Manufacturing
    • 300 - 400 Employee
    • Board of Directors
      • Oct 2008 - Jan 2014

      Audit Committee Chairman | 2008-2014 Compensation Committee | 2008-2012 Nominating/Governance Committee | 2008-2014 Special Committee | 2013 Audit Committee Chairman | 2008-2014 Compensation Committee | 2008-2012 Nominating/Governance Committee | 2008-2014 Special Committee | 2013

    • United States
    • Financial Services
    • 700 & Above Employee
    • Advisor, Contract Research
      • May 2010 - Dec 2010

    • COO/CFO
      • Apr 2008 - Aug 2010

    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Chief Financial Officer
      • Dec 2006 - Apr 2008

    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Chief Financial Officer
      • 2002 - 2006

Education

  • Fairfield University
    BS, Accounting
    1986 - 1990
  • University of Connecticut School of Business
    MBA, Finance
    1997 - 1999

Community

You need to have a working account to view this content. Click here to join now